FORTREARX EXPANSION IMPROVES PATIENT ACCESS CAPABILITIES, COLD CHAIN EXPERTISE

KUALA LUMPUR, Feb 21 (Bernama) -- Fortrea has announced the opening of its expanded non-commercial specialty pharmacy, FortreaRx, in Lake Mary, Florida, which offers advanced patient access solutions across the United States (US), including ambient and cold-chain distribution capabilities and expertise.

Fortrea vice president and global head of Patient Access, Bill Nolan in a statement said: “Fortrea’s well-established patient services offerings, combined with the expanded capabilities of FortreaRx, deliver an end-to-end approach, from early clinical stages to post-market delivery, ensuring a comprehensive and personalised experience for patients.”

Licenced in all 50 states and US territories, FortreaRx delivers flexible, scalable solutions that meet the specific needs of its customers while providing medications to patients who may otherwise not have access to them.

Non-commercial specialty pharmacies, such as FortreaRx, provide these solutions on behalf of their pharmaceutical manufacturer customers and are uniquely positioned to serve as a bridge between pharmaceutical manufacturers and patients who meet the manufacturer requirements for prescription assistance.

Since FortreaRx’s inception in late 2008, Fortrea has pioneered non-commercial specialty pharmacy services, focusing exclusively on the distribution of free-goods products as an integrated component of pharmaceutical manufacturer-sponsored patient assistance programmes (PAP) designed to expand access to therapy for qualified patients with no health insurance or those who are underinsured.

FortreaRx’s call centre hub of case managers seamlessly manages patient inquiries, counselling and data verification of prescriptions, in which Fortrea’s patient access team helps patients and providers understand and navigate the complexities of coverage while removing obstacles to get medication to patients.

FortreaRx delivers efficient, consultative and cost-effective solutions for manufacturer prescription programmes typically resulting in significant yearly savings for patients.

A global contract research organisation, providing clinical development and patient access solutions to the life sciences industry, Fortrea partners with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need.

-- BERNAMA